Overview
SRXH market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
SRX Global Inc is an AI-driven platform focused on investing in operating companies, strategic assets, and technology-enabled opportunities across multiple sectors. It uses technology and data analytics to identify and manage investments.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
SRXH price chart · 1M
- O
- 0.947000
- H
- 0.947000
- L
- 0.801600
- C
- 0.801600
- Vol
- 5,897.00
Daily history from Jun 29, 2021
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $0.95
- Previous Close
- $1.02
- Day High
- $0.95
- Day Low
- $0.80
- 52 Week High
- $41.42
- 52 Week Low
- $0.09
- 7 Day Return
- -16.48%
- 30 Day Return
- -28.75%
- 90 Day Return
- -56.08%
- 1 Year Return
- -94.49%
- Daily Notional Volume
- $4.7K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$127.94 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.03 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -58.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.71 – $42.61 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $16.1M · P/B 19.36 · P/S 0.37.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
SRX Global Provides Update on Engineered T-Cell Strategy and Pending CERo Therapeutics AcquisitionFiscal.ai ·
SRX Global Provides Update on Engineered T-Cell Strategy Following Pfizer–Starna Licensing AgreementGlobenewswire Inc ·
SRX Global Activates UC Davis as Clinical Trial Site for CERo Therapeutics' CER-1236 StudyFiscal.ai ·
8-K filing — SRX Global Inc. (SRXH)SEC EDGAR ·